Physician profile
Todd D Lindquist
NPI 1235181553
$1,839.95
in general payments reported to CMS, 2019-2025
14 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $332 · 2022: $300 · 2023: $394 · 2024: $171 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810 · Travel and Lodging: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.91 |
| Travel and Lodging | $212.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $959.68 | 2021-2025 | Nuvent, Propel, Stealthstation S8 Platform |
| Genzyme Corporation | $247.42 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $206.40 | 2021-2024 | Dupixent |
| Intersect Ent, INC. | $148.44 | 2019 | |
| Optinose US, INC. | $89.30 | 2021-2023 | |
| Kaleo, INC. | $47.14 | 2019-2022 | |
| Alk-Abello, INC | $25.14 | 2019-2022 | |
| Advanced Bionics, LLC | $23.72 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Stryker Corporation | $20.90 | 2022 | |
| Ambu INC. | $15.88 | 2025 | |
| Aerin Medical INC. | $14.92 | 2025 | |
| Paratek Pharmaceuticals, INC. | $14.42 | 2025 | Xhance |
| Integra Lifesciences Corporation | $14.32 | 2022 | |
| Genentech USA, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Lindquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.